Please wait...
About This Project
We hypothesize that targeted delivery of Curcumin to antigen presenting cells in the immune system can suppress tumor growth for a variety of cancers. This study will examine tumor responses to Curcumin in a colon cancer mouse model when given alone or in combination with an FDA-approved immune Checkpoint Inhibitor. Positive results will lead to Fast-Track FDA applications for human and companion pet animal cancer trials.
Recent Lab Notes From This Project

Browse Other Projects on Experiment
Related Projects
Are climate change and air pollution triggering cardiovascular disease?
Ongoing global climate change and air pollution emissions pose a major threat to cardiovascular health...
What kills elephants at waterholes in Zimbabwe?
Botswana recently experienced severe, highly publicized mortality of elephant, which authorities attribute...
Targeting the brain with Curcumin: Can we treat Chronic Traumatic Encephalopathy?
We have invented a Nanocarrier that targets the Immune System to deliver Curcumin, an anti-inflammatory...